Open AccessSafety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa
Author(s) -
Vassiliki Tzanetakou,
Theodora Kanni,
S. Giatrakou,
Alexander Katoulis,
Evangelia Papadavid,
Mihai G. Netea,
Charles A. Dinarello,
J.W.M. van der Meer,
Dimitrios Rigopoulos,
Evangelos J. GiamarellosBourboulis
Publication year - 2015
Publication title -
jama dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.128
H-Index - 166
eISSN - 2168-6084
pISSN - 2168-6068
DOI - 10.1001/jamadermatol.2015.3903
Subject(s) - medicine , anakinra , hidradenitis suppurativa , placebo , randomized controlled trial , clinical endpoint , exacerbation , discontinuation , surgery , disease , pathology , alternative medicine
Hidradenitis suppurativa (HS) is a common skin disorder in which excessive inflammation is believed to have an important role. There is no specific therapy for HS.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom